EU GMP injectable manufacturing plant in Spain for sale

 

  1. BUSINESS OVERVIEW:

 

Company founded in 2005 by a group of professionals from the pharmaceutical sector with the aim to manufacture and distribute healthcare and medicinal products in the hospital field.

 

  1. BUSINESS STRENGTHS:

 

The company complies with the EU GMP standard for injectible line and provide contract manufacturing servise to European pharmaceutical companies. 3 additional lines in ophtalmology is on the way to get EU GMP within 2017. 提供服务: 我) Manufacturing of liquid parenteral solutions with terminal sterilization in glass, 聚丙烯容器, PP bags from a 50ml to 3 litres ii) 盖仑开发和分析 iii) 稳定性测试 iv) 营销, 物流配送. 竞争优势: 我) tax incentives due to region in Spain, 二、) 资产 iii 没有贷款) 来自地面的水, 四号) New European machineries v) lower labor costs due to region in Spain vi) possible expansion without investment

 

  1. EXPANSION OPPORTUNITY:

  1. Great possibilities for geographic expansion into Spain and other European markets, 中东, 非洲, 亚洲, Americas Market whereas EU GMP is acceptable.

 

  1. 3 ophtalmology lines (1 multidose, 2 minidose) on the way to get EU GMP approval in 2017.

 

  1. 90% of factory capasities are free now, so company can rapidly grow using the existing base without additional investment.

 

  1. Own land is 5.000 平方米, 建筑 2.000 平方米

 

 

  1. MAIN PRODUCTS (contract manufacturing services)

 

CIPROFLOXACIN 2 MG/ML, 100 机器学习, 200机器学习 (制药)

 

FLUCONAZOL 2 MG/ML, 50 机器学习 (制药)

 

METRONIDAZOL 5 MG/ML, 100 机器学习 (制药)

 

STERILE WATER, 500 机器学习, 1000机器学习, 3000机器学习 (Medical Device, CE)

 

SOLUCION NaCl 0.9 % – 50, 100, 250, 500, 1000, 3000 机器学习 (Medical Device, CE)

 

SOLUCION GLUCOSE 1.5 %, 3000 机器学习 (Medical Device, CE)

 

 

 

 

 

 

 

  1. MAIN CUSTOMERS:

 

Contract manufaturing servise for European pharmaceutical companies Hospitals in Spain

 

6. PROFIT AND LOSS STATEMENT, 欧元  
  2016 2017
TURNOVER 300.000 600.000
OPERATING EXPENSES 360.000 360.000
PROFIT / LOSS -60.000 240.000
7. BALANCE, 欧元    
ASSET 3.000.000  
LAND + BUILDING 1.500.000  
MACHINERIES 1.500.000  
NO DEBTS    

 

 

  1. DEBTS:

 

无债务.

 

 

  1. NUMBER OF EMPLOYEES: 15

  1. TAX AND LABOR LIABILITIES:

 

There is no tax liability and no labor liabilities.

 

具体来说, in the Labour domain there is no action in progress.

 

 

  1. PHISICAL AREA OF THE COMPANY:

 

西班牙

 

 

土地 5.000
   
Building 2.000
   
Monthly Rental: No expensas, asset belongs to the company
   

 

 

 

 

 

 

 

 

 

  1. GENERAL INVENTORY:

 

Stock:

Machinery and Equipment Fixed assets:

 

 

 

 

 

1.500.000 欧元

 

 

 

  1. REASON FOR SALE:

 

Evaluating other business opportunities.

 

 

  1. SELLING PRICE AND CONDITIONS:

100% value for sale (Base date: 行进 2017) = 5.000.000 欧元

100% Cash payment

  1. ADDITIONAL INFORMATION:

Economic and financial diagnosis and companyVALUATIONwhen requested shall be provided during the DUE DILIGENCE, after expressions of interest from the investor group and signed Confidentiality Agreement (NDA).

 

  1. SALES PROCESS:

  1. Information Memorandum distribution to Pipelinepharma networking

 

  1. Investor written confirmation of interest with a LOI (letter of intent) or NBO (non-binding offer)

 

  1. Visit a plant, meeting sellers, Due Diligence

 

  1. Binding offer

 

  1. Share transfer agreement

 

 

     


    国家统计局科学

    合同研究组织